L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 38.322 GBX -0.72% Market Closed
Market Cap: 134.1m GBX
Have any thoughts about
Life Science REIT PLC?
Write Note

Life Science REIT PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Life Science REIT PLC
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
L
Life Science REIT PLC
LSE:LABS
Cost of Revenue
-£6.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Primary Health Properties PLC
LSE:PHP
Cost of Revenue
-£25.5m
CAGR 3-Years
-44%
CAGR 5-Years
-43%
CAGR 10-Years
-45%
Assura PLC
LSE:AGR
Cost of Revenue
-£14.5m
CAGR 3-Years
-18%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Target Healthcare REIT PLC
LSE:THRL
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Impact Healthcare REIT PLC
LSE:IHR
Cost of Revenue
-£795k
CAGR 3-Years
-21%
CAGR 5-Years
-47%
CAGR 10-Years
N/A
No Stocks Found

Life Science REIT PLC
Glance View

Market Cap
134.1m GBX
Industry
Real Estate

Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.

LABS Intrinsic Value
56.874 GBX
Undervaluation 33%
Intrinsic Value
Price
L

See Also

What is Life Science REIT PLC's Cost of Revenue?
Cost of Revenue
-6.1m GBP

Based on the financial report for Dec 31, 2023, Life Science REIT PLC's Cost of Revenue amounts to -6.1m GBP.

What is Life Science REIT PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-28%

Over the last year, the Cost of Revenue growth was -28%.

Back to Top